JP6855372B2 - その必要がある対象の飽食を誘導し、満腹を延長させる医薬組成物および食品組成物 - Google Patents

その必要がある対象の飽食を誘導し、満腹を延長させる医薬組成物および食品組成物 Download PDF

Info

Publication number
JP6855372B2
JP6855372B2 JP2017517358A JP2017517358A JP6855372B2 JP 6855372 B2 JP6855372 B2 JP 6855372B2 JP 2017517358 A JP2017517358 A JP 2017517358A JP 2017517358 A JP2017517358 A JP 2017517358A JP 6855372 B2 JP6855372 B2 JP 6855372B2
Authority
JP
Japan
Prior art keywords
protein
clpb
coli
food
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017517358A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018503597A5 (cg-RX-API-DMAC10.html
JP2018503597A (ja
Inventor
フェティソヴ，セルゲイ
デチェロッテ，ピエール
ブレトン，ジョナサン
ランバート，グレゴリー
Original Assignee
インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル）
インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル）
センター ホスピタリエ ユニバーシティ デ ロウエン
センター ホスピタリエ ユニバーシティ デ ロウエン
ユニバーシティ デ ロウエン
ユニバーシティ デ ロウエン
タージェディズ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル）, インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル）, センター ホスピタリエ ユニバーシティ デ ロウエン, センター ホスピタリエ ユニバーシティ デ ロウエン, ユニバーシティ デ ロウエン, ユニバーシティ デ ロウエン, タージェディズ filed Critical インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル）
Publication of JP2018503597A publication Critical patent/JP2018503597A/ja
Publication of JP2018503597A5 publication Critical patent/JP2018503597A5/ja
Application granted granted Critical
Publication of JP6855372B2 publication Critical patent/JP6855372B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2017517358A 2014-10-02 2015-06-05 その必要がある対象の飽食を誘導し、満腹を延長させる医薬組成物および食品組成物 Active JP6855372B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14306552 2014-10-02
PCT/IB2015/001126 WO2016059455A1 (en) 2014-10-02 2015-06-05 Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019182616A Division JP2020015757A (ja) 2019-10-03 2019-10-03 その必要がある対象の飽食を誘導し、満腹を延長させる医薬組成物および食品組成物

Publications (3)

Publication Number Publication Date
JP2018503597A JP2018503597A (ja) 2018-02-08
JP2018503597A5 JP2018503597A5 (cg-RX-API-DMAC10.html) 2018-05-24
JP6855372B2 true JP6855372B2 (ja) 2021-04-07

Family

ID=51799054

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017517358A Active JP6855372B2 (ja) 2014-10-02 2015-06-05 その必要がある対象の飽食を誘導し、満腹を延長させる医薬組成物および食品組成物
JP2017563130A Active JP6876627B2 (ja) 2014-10-02 2016-04-05 必要とする対象に飽満感を誘発し満腹感を持続させる医薬組成物および食品組成物
JP2019503629A Active JP6987122B2 (ja) 2014-10-02 2017-04-05 飽満感を誘発し満腹感を持続させる、ハフニア・アルベイ（Ｈａｆｎｉａ ａｌｖｅｉ）ベースの医薬組成物および食品組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017563130A Active JP6876627B2 (ja) 2014-10-02 2016-04-05 必要とする対象に飽満感を誘発し満腹感を持続させる医薬組成物および食品組成物
JP2019503629A Active JP6987122B2 (ja) 2014-10-02 2017-04-05 飽満感を誘発し満腹感を持続させる、ハフニア・アルベイ（Ｈａｆｎｉａ ａｌｖｅｉ）ベースの医薬組成物および食品組成物

Country Status (14)

Country Link
US (3) US20170252399A1 (cg-RX-API-DMAC10.html)
EP (2) EP3200814B1 (cg-RX-API-DMAC10.html)
JP (3) JP6855372B2 (cg-RX-API-DMAC10.html)
KR (3) KR20170066543A (cg-RX-API-DMAC10.html)
CN (2) CN106999545B (cg-RX-API-DMAC10.html)
AU (2) AU2015332168B2 (cg-RX-API-DMAC10.html)
BR (2) BR112017006770A2 (cg-RX-API-DMAC10.html)
CA (1) CA2962907C (cg-RX-API-DMAC10.html)
ES (3) ES2828952T3 (cg-RX-API-DMAC10.html)
IL (1) IL256136B (cg-RX-API-DMAC10.html)
MX (3) MX386374B (cg-RX-API-DMAC10.html)
PT (1) PT3439684T (cg-RX-API-DMAC10.html)
RU (3) RU2717018C2 (cg-RX-API-DMAC10.html)
WO (2) WO2016059455A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10729770B2 (en) 2013-12-05 2020-08-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
WO2016193829A1 (en) * 2015-06-05 2016-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof.
RU2717018C2 (ru) * 2014-10-02 2020-03-17 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Фармацевтические и пищевые композиции для индукции насыщения и продления чувства сытости у нуждающихся в этом субъектов
EP3384922A1 (en) * 2017-04-03 2018-10-10 Targedys Brassicaceae protein extract and uses thereof
FR3076981B1 (fr) * 2018-01-19 2020-01-31 Zhivko Radev Methode de fabrication de produits alimentaires a base de yaourt
CN108715851B (zh) * 2018-04-28 2023-05-16 中山大学 一种斜带石斑鱼摄食调控相关基因AgRP1及其应用
EP3886882A1 (en) 2018-11-28 2021-10-06 Targedys Hafnia alvei formulations
JP2022510891A (ja) * 2018-11-28 2022-01-28 タージェディズ 無機成分を含むハフニア・アルベイ（Ｈａｆｎｉａ ａｌｖｅｉ）組成物
MY189523A (en) * 2019-05-22 2022-02-16 Mizkan Holdings Co Ltd Solid composition containing insoluble dietary fiber and method for manufacturing the same
KR102973977B1 (ko) * 2021-11-26 2026-06-09 충남대학교산학협력단 알파-멜라노사이트 자극 호르몬의 펩티드 변이체 및 이의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003359A1 (en) * 1995-07-07 1997-01-30 Oravax, Inc. Helicobacter clpb
WO1999048372A1 (en) 1998-03-23 1999-09-30 General Mills, Inc. Encapsulation of components into edible products
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
MX2008009726A (es) * 2006-01-27 2009-03-05 Danisco Uso de microorganismos probioticos para el tratamiento y prevencion de la obesidad y trastornos relacionados.
JP2009534034A (ja) * 2006-04-19 2009-09-24 ノヴォ ノルディスク アクティーゼルスカブ 原核微生物におけるｏ−グリコシル化治療用タンパク質の発現
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
EP2053122A1 (en) * 2007-10-23 2009-04-29 Nestec S.A. Stress tolerant bifidobacteria
IN2014DN07752A (cg-RX-API-DMAC10.html) * 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
US10729770B2 (en) * 2013-12-05 2020-08-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
WO2016193829A1 (en) * 2015-06-05 2016-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof.
CN105979957A (zh) * 2013-12-05 2016-09-28 国家医疗保健研究所 细菌通过模拟α-MSH的CLPB蛋白对宿主进食与情绪的影响
PL3076985T3 (pl) * 2013-12-05 2024-12-16 Institut National De La Santé Et De La Recherche Médicale (Inserm) Kompozycja zawierająca probiotyki z nadekspresją białka clpb do zastosowania w leczeniu otyłości
RU2717018C2 (ru) * 2014-10-02 2020-03-17 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Фармацевтические и пищевые композиции для индукции насыщения и продления чувства сытости у нуждающихся в этом субъектов

Also Published As

Publication number Publication date
MX2017004317A (es) 2017-10-04
RU2017110516A3 (cg-RX-API-DMAC10.html) 2018-11-05
MX2017015702A (es) 2018-12-11
RU2717018C2 (ru) 2020-03-17
JP6876627B2 (ja) 2021-06-02
IL256136A (en) 2018-02-28
RU2017142932A (ru) 2019-07-11
WO2017174658A1 (en) 2017-10-12
EP3769777B9 (en) 2022-10-26
MX386374B (es) 2025-03-18
EP3769777A1 (en) 2021-01-27
CA3020050A1 (en) 2017-10-12
MX2018012056A (es) 2019-03-28
JP2019513832A (ja) 2019-05-30
AU2015332168B2 (en) 2021-02-25
RU2017110516A (ru) 2018-11-05
US11389489B2 (en) 2022-07-19
RU2018138995A3 (cg-RX-API-DMAC10.html) 2020-11-09
US10888592B2 (en) 2021-01-12
IL256136B (en) 2021-02-28
RU2766585C2 (ru) 2022-03-15
EP3200814A1 (en) 2017-08-09
RU2018138995A (ru) 2020-05-12
ES2928379T3 (es) 2022-11-17
JP2018521982A (ja) 2018-08-09
EP3769777B1 (en) 2022-07-27
AU2016272850A1 (en) 2017-12-21
CN106999545A (zh) 2017-08-01
KR20170066543A (ko) 2017-06-14
US20170252399A1 (en) 2017-09-07
BR112017006770A2 (pt) 2018-11-06
AU2015332168A1 (en) 2017-04-20
ES2808939T3 (es) 2021-03-02
ES2828952T3 (es) 2021-05-28
KR102472169B1 (ko) 2022-11-29
WO2016059455A1 (en) 2016-04-21
US20200297783A1 (en) 2020-09-24
HK1252744A1 (zh) 2019-05-31
CN106999545B (zh) 2021-09-21
JP2018503597A (ja) 2018-02-08
RU2017142932A3 (cg-RX-API-DMAC10.html) 2019-07-17
PT3439684T (pt) 2020-07-31
KR20180011841A (ko) 2018-02-02
CN109310736B (zh) 2022-09-13
US20190142876A1 (en) 2019-05-16
KR20190010543A (ko) 2019-01-30
BR112017026241A2 (pt) 2018-09-11
CA2962907C (en) 2022-06-07
JP6987122B2 (ja) 2022-01-05
CA2962907A1 (en) 2016-04-21
CN109310736A (zh) 2019-02-05
EP3200814B1 (en) 2020-09-23

Similar Documents

Publication Publication Date Title
US11389489B2 (en) Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof
JP2018503597A5 (cg-RX-API-DMAC10.html)
US10682389B2 (en) Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof
JP2018521982A5 (cg-RX-API-DMAC10.html)
EP3439684B1 (en) Hafnia alvei based pharmaceutical and food compositions for inducing satiation and prolonging satiety
JP2020015757A (ja) その必要がある対象の飽食を誘導し、満腹を延長させる医薬組成物および食品組成物
Class et al. Patent application title: PHARMACEUTICAL AND FOOD COMPOSITIONS FOR INDUCING SATIATION AND PROLONGING SATIETY IN SUBJECTS IN NEED THEREOF
HK1252744B (en) Food compositions for inducing satiation and prolonging satiety in subjects in need thereof
HK1238154B (en) Food compositions for inducing satiation and prolonging satiety in subjects in need thereof
HK40004392B (en) Hafnia alvei based pharmaceutical and food compositions for inducing satiation and prolonging satiety
HK40004392A (en) Hafnia alvei based pharmaceutical and food compositions for inducing satiation and prolonging satiety

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170529

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180123

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180123

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180405

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181016

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190110

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190314

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190415

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20190416

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190604

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191003

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20191003

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20191021

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20191220

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20191224

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20200117

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20200121

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20200414

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20200929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201221

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20210119

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20210222

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20210222

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210317

R150 Certificate of patent or registration of utility model

Ref document number: 6855372

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250